Table 3 Cox regression models showing adjusted HRs of cardiometabolic comorbidities among PTSD patients compared to the population without PTSD
From: The impact of PTSD on risk of cardiometabolic diseases: a national patient cohort study in Norway
Event outcomes | Model 1 HR (99% CI) | Model 2 HR (99% CI) | Model 3 HR (99% CI) | Model 4 HR (99% CI) | Model 5 HR (99% CI) | Model 6 HR (99% CI) |
|---|---|---|---|---|---|---|
Hypertensive diseases | 3.5 (3.1–3.9) | 3.1 (2.7–3.5) | 2.6 (2.3–2.9) | 2.4 (2.1–2.7) | 1.8 (1.6–2.1) | 1.8 (1.6–2.1) |
Ischaemic heart diseases | 4.2 (3.6–5.0) | 3.6 (3.1–4.3) | 2.9 (2.5–3.5) | 2.7 (2.3–3.2) | 2.0 (1.7–2.4) | 2.0 (1.7–2.4) |
Pulmonary heart diseases | 4.6 (3.1–6.8) | 3.8 (2.6–5.7) | 2.9 (1.9–4.3) | 2.7 (1.8–4.0) | 1.9 (1.3–2.9) | 1.9 (1.2–2.8) |
Cerebrovascular diseases | 4.2 (3.3–5.4) | 3.5 (2.7–4.5) | 2.8 (2.1–3.6) | 2.5 (1.9–3.2) | 1.8 (1.4–2.4) | 1.8 (1.4–2.3) |
Diabetes mellitus | 5.0 (4.3–5.8) | 4.1 (3.5–4.7) | 3.3 (2.8–3.8) | 3.1 (2.6–3.6) | 2.2 (1.9–2.6) | 2.2 (1.9–2.6) |
Obesity | 6.5 (5.7–7.5) | 5.0 (4.3–5.7) | 3.6 (3.1–4.2) | 3.4 (2.9–3.9) | 2.1 (1.8–2.4) | 2.0 (1.8–2.3) |
Metabolic disorders | 6.2 (5.5–6.9) | 5.0 (4.5–5.6) | 3.7 (3.3–4.1) | 3.1 (2.8–3.5) | 2.3 (2.1–2.6) | 2.2 (2.0–2.5) |